Midcap outperforms Sensex, Nifty reclaims 9750; Dr Reddy’s up 4%

Epic Update Dr Reddy's LabsEpic Update Dr Reddy's Labs

Equity benchmarks remained positive amid consolidation in late morning trade, with the Nifty reclaiming 9,750 ahead of expiry of September futures & options contracts.

The 30-share BSE Sensex was up 82.83 points at 31,242.64 and the 50-share NSE Nifty rose 11.60 points to 9,747.35.

After recovery in early trade, the broader markets strengthened further as the BSE Midcap index was up 0.85 percent and Smallcap gained 0.7 percent on strong breadth.

About two shares advanced for every share falling on the BSE.

Dr Reddy’s Labs today informed exchanges that it has received establishment inspection report from the US Food and Drug Administration for SriKakulam plant (SEZ) unit 1, Andhra Pradesh.

For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co

Facebook Twitter YouTube Pinterest Linkedin Google+

You may also like:

Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited' width= Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed' width=
Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed
Share Button

About the Author

Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300